NEW YORK (GenomeWeb News) - The Georgia Institute of Technology has purchased a Nano eNabler molecular printing system from BioForce Nanosciences, the company said today.
BioForce said the Nano eNabler can be used in patterning and cell adhesion, for printing proteins to direct neural cell growth, and in sensor functionalization.
The company sold the Nano eNabler to Georgia Tech through a pilot program that involved placing the tool in 20 biomedical and life sciences facilities for trial use.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.